Teva Pharmaceutical Industries (TEVA) total debt

Total debt · fiscal 2025
$17.09B

Teva Pharmaceutical Industries (TEVA) carried total debt of $17.09B at the end of fiscal 2025 (December 31, 2025). That is 5.4% lower than the $18.08B of fiscal 2024. Figures as of 18 Nov 2026, 09:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$17.09B
Change on fiscal 2024
−5.4%
Growth, 10 years
+6.1% a year
Highest on record
$33.35Bfiscal 2016
Lowest on record
$4.62Bfiscal 2009
Fiscal years on record
132009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Teva Pharmaceutical Industries total debt, in more detail

Over the ten fiscal years to 2025 total debt grew at a compound 6.1% a year. Across the 13 fiscal years on record (2009–2025), the highest was $33.35B in fiscal 2016 and the lowest $4.62B in fiscal 2009.

Total debt was 2.2× shareholders' equity at the end of fiscal 2025.

History · 13 fiscal years

Total debt by fiscal year

Teva Pharmaceutical Industries total debt, year by year

Teva Pharmaceutical Industries (TEVA) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$17.09B 5.4% down2.2×
2024$18.08B 10.3% down3.4×
2023$20.15B 6.5% down2.7×
2022$21.56B—2.8×
2017$31.71B 4.9% down1.8×
2016$33.35B 253.9% up1.0×
2015$9.42B 3.8% down0.3×
2014$9.80B 18.5% down0.4×
2013$12.02B 27.5% down0.5×
2012$16.57B 32.0% up0.7×
2011$12.55B 128.6% up0.6×
2010$5.49B 18.8% up0.3×
2009$4.62B—0.2×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Teva Pharmaceutical Industries and comparable companies
CompanyTotal debtFiscal year
Medline MDLN$12.63B2025
Humana HUM$12.37B2025
Agilent Technologies A$3.35B2025
Teva Pharmaceutical Industries TEVA$17.09B2025
BeOne Medicines ONC$1.09B2025
Waters WAT$1.49B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TEVA

Teva Pharmaceutical Industries, figure by figure

Teva Pharmaceutical Industries (TEVA) overview: price, valuation and scorecardAll health care companies by market value

Teva Pharmaceutical Industries total debt: questions and answers

How much debt does Teva Pharmaceutical Industries have?

Teva Pharmaceutical Industries (TEVA) carried total debt of $17.09B at the end of fiscal 2025 (December 31, 2025). That is 5.4% lower than the $18.08B of fiscal 2024.

What is the growth rate of Teva Pharmaceutical Industries's total debt?

Over the ten fiscal years to 2025 total debt grew at a compound 6.1% a year.

What are the highest and lowest total debt figures on record for Teva Pharmaceutical Industries?

Across the 13 fiscal years on record (2009–2025), the highest was $33.35B in fiscal 2016 and the lowest $4.62B in fiscal 2009.

How does Teva Pharmaceutical Industries's debt compare with its equity?

Total debt was 2.2× shareholders' equity at the end of fiscal 2025.

How is Teva Pharmaceutical Industries's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Teva Pharmaceutical Industries it is on record here for 13 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Teva Pharmaceutical Industries (TEVA) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/TEVA/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.